fbpx
QQQ
-2.71
348.05
-0.78%
DIA
-5.86
344.51
-1.73%
SPY
-7.07
429.04
-1.68%
TLT
+ 2.69
140.35
+ 1.88%
GLD
-0.87
166.72
-0.52%

What's Going On With Bionano Genomics Stock Today?

April 26, 2021 2:49 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
What's Going On With Bionano Genomics Stock Today?

BioNano Genomics Inc (NASDAQ:BNGO) shares are trading higher by 19.5% at $7.36 Monday on continued strength following last week’s publication of DNA replication data, a fundamental process of cell growth implicated in cancer that was previously hard to study in human genomes. 

Bionano Genomics is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

See also: How to Buy Bionano Genomics Inc. (BNGO) Stock

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.


Related Articles

60 Biggest Movers From Yesterday

Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. read more

35 Stocks Moving In Monday's Mid-Day Session

Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares jumped 64.8% to $8.04 on abnormally-high session volume. read more

Bionano Runs Higher Following CCO Appointment

Bionano Genomics Inc. (NASDAQ: BNGO) shares climbed higher Monday after the company appointed Jason Priar as its Chief Commercial Officer. read more

22 Stocks Moving in Monday's Pre-Market Session

Gainers Liminal BioSciences Inc. (NASDAQ: LMNL) rose 51.7% to $6.10 in pre-market trading. Liminal BioSciences reported the FDA approval for its Biologics License Application for Ryplazim. read more